Flora Growth Corp. (FLGC)

Flora Growth Corp.'s stock experienced significant volatility over the past six months. On September 30, 2025, shares plunged due to new private placements. On October 1, 2025, the stock rebounded. On October 7, 2025, shares fell due to uncertainty surrounding digital asset integration. On October 8, 2025, the stock rallied after an inaugural 0G token purchase. On October 10, 2025, FLGC shares tumbled as investors became wary of operational execution. On October 16, 2025, a decline occurred due to skepticism after Flora Growth appointed BitGo Trust as custodian for its 0G treasury. On October 21, 2025, FLGC dropped after announcing a second major $0G token purchase. On October 22, 2025, an additional decline followed news of digital asset expansion. On October 27, 2025, shares dropped amidst sustained selling pressure. On November 5, 2025, Flora Growth Corp. reported a Q3 loss. On November 13, 2025, SRx Health Solutions appointed Sammy Dorf to its Board of Directors. On November 22, 2025, Flora Growth's stock rating was lowered. On November 23 and 24, 2025, shares experienced upward movement. The share price as of November 25, 2025, was $7.79, representing a significant decline from the previous year.

Specific seasonality data for Flora Growth Corp.'s products is not publicly available. However, sales of $600,000 were reported over the Black Friday and Cyber Monday weekend in 2024 across its JustCBD and Vessel brands, indicating increased demand during holiday shopping periods. Consumer-focused products may experience higher demand during major retail events and holidays.

Flora Growth Corp. cultivates, processes, and supplies medicinal-grade cannabis flower, as well as cannabis-derived medical and wellness products. The House of Brands segment includes food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness products, featuring CBD items like gummies, topicals, and vape products. The Commercial and Wholesale segment distributes pharmaceutical products internationally. Brands include JustCBD and Vessel. The company also manufactures and distributes pharmaceutical goods and medical cannabis products for various health indications.

Flora Growth Corp. has cultivation operations in Colombia at its Cosechemos facility and is headquartered in Fort Lauderdale, Florida. It generates revenue from the United States, Germany, Australia, and the United Kingdom, with the majority from the United States. The company has expanded in Europe and the UK, with offices in London and distribution centers in the UK and Netherlands. Through a partnership with Hoshi, Flora Growth distributes its product portfolio to 11 European countries.

Specific details on events affecting Flora Growth Corp.'s brand reputation are not readily available. The company emphasizes brand building and the performance of brands like JustCBD and Vessel, focusing on natural ingredients and sustainability. Stock price volatility and a pivot towards digital assets could indirectly influence investor perception, but direct impacts on consumer brand reputation are not explicitly mentioned.

Flora Growth Corp. has a mix of institutional and individual ownership. Institutional investors hold 7.68% of the shares, with major holders including UBS Group AG and Morgan Stanley. Individual insider ownership is substantial, with insiders owning 1,270.71% of the company's stock. Clifford Starke is the largest individual shareholder.